2025 H1 -tulosraportti
118 päivää sitten48 min
Tarjoustasot
First North Denmark
Määrä
Osto
3 538 467
Myynti
Määrä
326 000
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| - | - | - | - |
Ylin
0,01VWAP
Alin
0,009VaihtoMäärä
0 2 239 767
VWAP
Ylin
0,01Alin
0,009VaihtoMäärä
0 2 239 767
Välittäjätilasto
Dataa ei löytynyt
Yhtiötapahtumat
| Seuraava tapahtuma | |
|---|---|
Sijoittajakalenteri ei ole saatavilla | |
| Menneet tapahtumat | ||
|---|---|---|
| 2025 H1 -tulosraportti | 4.9. | |
| 2024 H2 -tulosraportti | 29.4. | |
| 2024 H1 -tulosraportti | 3.9.2024 | |
| 2023 H2 -tulosraportti | 7.5.2024 | |
| 2023 H1 -tulosraportti | 1.9.2023 |
Datan lähde: Quartr
Asiakkaat katsoivat myös
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
·1 päivä sittenAnother bird has joined the flock on the roof. If one reads g-cloud prices and discounts, it will make sense. https://www.linkedin.com/posts/national-institute-for-health-and-care-excellence_nice-and-the-10-year-health-plan-for-the-activity-7411330378394710016-6odf?utm_source=share&utm_medium=member_android&rcm=ACoAAB5yFvMBGDwma3GIsqrlG98N5EDm84BK3K4
·1 päivä sittenCould a collaboration with Novo Nordisk be an advantage? They primarily focus on the development of innovative biological medicines but are now also Alzheimer's disease through medical research. Brain+ is, on the other hand, a medtech company that develops digital health solutions for cognitive rehabilitation for citizens with acquired brain injury or dementia. Although both companies operate within the healthcare sector in Denmark, their business areas and methods are different. But they both help to focus on Alzheimer's and they could gather knowledge that both could benefit from, either through shared data or advertising.
·23.12.Merry Christmas to everyone here in the forum, hope you all get time to enjoy the time with your families and friends.
·24.12.Same to you! 🤗😊.. Also to you two, Overleif and Sir Simon! 🎁🎅🤶🎄..- ·23.12.If one still can't quite get an overview of what brain+ and Ayla are today, I have made a fact sheet with only data and no noise. 🏛 National and Supranational Health Systems NHS Europe's largest public health system. Defines standards for treatment, evidence, and implementation. Reference for many countries outside the UK. Entry point for national rollout via the ICS structure. If something is accepted here, it is systemically legitimate. World Health Organization Global norm and guideline setter. CST is WHO-recommended. Digital therapeutics with documented effect are prioritized globally. WHO creates global demand – not local pilots. Alzheimer’s Society UK's strongest dementia organization. Professional authority and political voice. Closely linked to NHS, research, and lived experience. Support here = professional endorsement. 🧠 NHS' internal structure NHS Clinical Entrepreneur Programme Selects solutions NHS itself sees scaling potential in. Focus on evidence, implementation, and system fit. NHS says here: “we need to test this one”. Integrated Care Systems 42 regional systems in England. Gathers hospitals, municipalities, care homes, and budgets. This is where rollout decisions are made. Ayla matches the ICS logic: prevention and community care. 🏢 Care sector's power centers Care England The most powerful industry organization for private care homes in the UK. Represents large chains and care groups. Close dialogue with politicians, CQC, and NHS. Access here = access to hundreds of homes. Care Quality Commission Regulator for quality in care homes. Focus on evidence, documentation, medication reduction, and meaningful activity. Ayla directly addresses CQC's criticisms. 🏆 Recognition and legitimacy HSJ Partnership Awards NHS' most prestigious award for partnerships. Shortlisting = national recognition of model and practice, not marketing. UK Dementia Congress National professional platform for dementia. Participation is by invitation. Here the field's common direction is shaped. 🌍 International policy and longevity scenes Longevity Show Gathers WHO, policy, clinical, and system actors. Focus on implementable solutions. Participation signals global relevance. 🇩🇰 Denmark, public welfare systems Danish municipalities: Copenhagen Municipality, Aarhus Municipality, Syddjurs Municipality. Via co-PI, testing, and education. Shows transferability to Nordic welfare systems. 🔗 Overall picture This is not one sector, but an entire ecosystem: Public health system (NHS), regional decision-making structure (ICS), national regulator (CQC), industry organization (Care England), global norm-setter (WHO), national dementia authority (Alzheimer’s Society), international policy scenes, and municipal welfare systems (DK). All are moving in the same direction. 🎯 Conclusion If one still sees Brain+ / Ayla as “a small company hoping for a breakthrough”, one overlooks that they are already working in the right systems, speaking the right language, and being evaluated by the right instances. That is the league where large contracts are formed, often long before the market discovers it.
·23.12.B- Leif: as the old proverb says: “birds on the roof are good, many birds on the roof are very good - because suddenly one of them is a GOLDBIRD” So now go and put the Duck on for long-term roasting, Leif 👨🏼🍳🤡 - ·22.12.It will be fun to follow how many 5 kr sales downwards we can count today, after a lift 😅🧐🧐 good day.
·22.12.Thought there was an agreement to ignore the price for the rest of 2025 and wait for a green and rising 2026 🤣📈·22.12. · MuokattuI actually think it's more about so much else😊 I feel I have a pretty in-depth insight into the case, so I'm really not that affected by it flying a bit up and down during the day. I just can't help but find it peculiar that we so often see trades that are quite high in level, only to be sold down right after by 5 kr. It's not about frustration at all, it's about wonder and a search for logic. There are several things to it. Firstly, fair enough if you just need 5 kr for the bus. Then you'll have to sell off a bit. Next, there's no economic logic in selling at a loss when you've just seen a higher level. And lastly, why exactly after a larger trade that is 10% higher🤷 The only logical explanation must be that some out there get a kick out of being able to manipulate the market by 10% for 5kr.. and here I'm not thinking of anyone in particular 🧐 I just smile and say thank you very much for another fantastic trade 😅😅 the window at this level is getting shorter and shorter day by day..
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
2025 H1 -tulosraportti
118 päivää sitten48 min
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
- ·1 päivä sittenAnother bird has joined the flock on the roof. If one reads g-cloud prices and discounts, it will make sense. https://www.linkedin.com/posts/national-institute-for-health-and-care-excellence_nice-and-the-10-year-health-plan-for-the-activity-7411330378394710016-6odf?utm_source=share&utm_medium=member_android&rcm=ACoAAB5yFvMBGDwma3GIsqrlG98N5EDm84BK3K4
- ·1 päivä sittenCould a collaboration with Novo Nordisk be an advantage? They primarily focus on the development of innovative biological medicines but are now also Alzheimer's disease through medical research. Brain+ is, on the other hand, a medtech company that develops digital health solutions for cognitive rehabilitation for citizens with acquired brain injury or dementia. Although both companies operate within the healthcare sector in Denmark, their business areas and methods are different. But they both help to focus on Alzheimer's and they could gather knowledge that both could benefit from, either through shared data or advertising.
- ·23.12.Merry Christmas to everyone here in the forum, hope you all get time to enjoy the time with your families and friends.·24.12.Same to you! 🤗😊.. Also to you two, Overleif and Sir Simon! 🎁🎅🤶🎄..
- ·23.12.If one still can't quite get an overview of what brain+ and Ayla are today, I have made a fact sheet with only data and no noise. 🏛 National and Supranational Health Systems NHS Europe's largest public health system. Defines standards for treatment, evidence, and implementation. Reference for many countries outside the UK. Entry point for national rollout via the ICS structure. If something is accepted here, it is systemically legitimate. World Health Organization Global norm and guideline setter. CST is WHO-recommended. Digital therapeutics with documented effect are prioritized globally. WHO creates global demand – not local pilots. Alzheimer’s Society UK's strongest dementia organization. Professional authority and political voice. Closely linked to NHS, research, and lived experience. Support here = professional endorsement. 🧠 NHS' internal structure NHS Clinical Entrepreneur Programme Selects solutions NHS itself sees scaling potential in. Focus on evidence, implementation, and system fit. NHS says here: “we need to test this one”. Integrated Care Systems 42 regional systems in England. Gathers hospitals, municipalities, care homes, and budgets. This is where rollout decisions are made. Ayla matches the ICS logic: prevention and community care. 🏢 Care sector's power centers Care England The most powerful industry organization for private care homes in the UK. Represents large chains and care groups. Close dialogue with politicians, CQC, and NHS. Access here = access to hundreds of homes. Care Quality Commission Regulator for quality in care homes. Focus on evidence, documentation, medication reduction, and meaningful activity. Ayla directly addresses CQC's criticisms. 🏆 Recognition and legitimacy HSJ Partnership Awards NHS' most prestigious award for partnerships. Shortlisting = national recognition of model and practice, not marketing. UK Dementia Congress National professional platform for dementia. Participation is by invitation. Here the field's common direction is shaped. 🌍 International policy and longevity scenes Longevity Show Gathers WHO, policy, clinical, and system actors. Focus on implementable solutions. Participation signals global relevance. 🇩🇰 Denmark, public welfare systems Danish municipalities: Copenhagen Municipality, Aarhus Municipality, Syddjurs Municipality. Via co-PI, testing, and education. Shows transferability to Nordic welfare systems. 🔗 Overall picture This is not one sector, but an entire ecosystem: Public health system (NHS), regional decision-making structure (ICS), national regulator (CQC), industry organization (Care England), global norm-setter (WHO), national dementia authority (Alzheimer’s Society), international policy scenes, and municipal welfare systems (DK). All are moving in the same direction. 🎯 Conclusion If one still sees Brain+ / Ayla as “a small company hoping for a breakthrough”, one overlooks that they are already working in the right systems, speaking the right language, and being evaluated by the right instances. That is the league where large contracts are formed, often long before the market discovers it.·23.12.B- Leif: as the old proverb says: “birds on the roof are good, many birds on the roof are very good - because suddenly one of them is a GOLDBIRD” So now go and put the Duck on for long-term roasting, Leif 👨🏼🍳🤡
- ·22.12.It will be fun to follow how many 5 kr sales downwards we can count today, after a lift 😅🧐🧐 good day.·22.12.Thought there was an agreement to ignore the price for the rest of 2025 and wait for a green and rising 2026 🤣📈·22.12. · MuokattuI actually think it's more about so much else😊 I feel I have a pretty in-depth insight into the case, so I'm really not that affected by it flying a bit up and down during the day. I just can't help but find it peculiar that we so often see trades that are quite high in level, only to be sold down right after by 5 kr. It's not about frustration at all, it's about wonder and a search for logic. There are several things to it. Firstly, fair enough if you just need 5 kr for the bus. Then you'll have to sell off a bit. Next, there's no economic logic in selling at a loss when you've just seen a higher level. And lastly, why exactly after a larger trade that is 10% higher🤷 The only logical explanation must be that some out there get a kick out of being able to manipulate the market by 10% for 5kr.. and here I'm not thinking of anyone in particular 🧐 I just smile and say thank you very much for another fantastic trade 😅😅 the window at this level is getting shorter and shorter day by day..
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
First North Denmark
Määrä
Osto
3 538 467
Myynti
Määrä
326 000
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| - | - | - | - |
Ylin
0,01VWAP
Alin
0,009VaihtoMäärä
0 2 239 767
VWAP
Ylin
0,01Alin
0,009VaihtoMäärä
0 2 239 767
Välittäjätilasto
Dataa ei löytynyt
Asiakkaat katsoivat myös
Yhtiötapahtumat
| Seuraava tapahtuma | |
|---|---|
Sijoittajakalenteri ei ole saatavilla | |
| Menneet tapahtumat | ||
|---|---|---|
| 2025 H1 -tulosraportti | 4.9. | |
| 2024 H2 -tulosraportti | 29.4. | |
| 2024 H1 -tulosraportti | 3.9.2024 | |
| 2023 H2 -tulosraportti | 7.5.2024 | |
| 2023 H1 -tulosraportti | 1.9.2023 |
Datan lähde: Quartr
2025 H1 -tulosraportti
118 päivää sitten48 min
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Yhtiötapahtumat
| Seuraava tapahtuma | |
|---|---|
Sijoittajakalenteri ei ole saatavilla | |
| Menneet tapahtumat | ||
|---|---|---|
| 2025 H1 -tulosraportti | 4.9. | |
| 2024 H2 -tulosraportti | 29.4. | |
| 2024 H1 -tulosraportti | 3.9.2024 | |
| 2023 H2 -tulosraportti | 7.5.2024 | |
| 2023 H1 -tulosraportti | 1.9.2023 |
Datan lähde: Quartr
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
- ·1 päivä sittenAnother bird has joined the flock on the roof. If one reads g-cloud prices and discounts, it will make sense. https://www.linkedin.com/posts/national-institute-for-health-and-care-excellence_nice-and-the-10-year-health-plan-for-the-activity-7411330378394710016-6odf?utm_source=share&utm_medium=member_android&rcm=ACoAAB5yFvMBGDwma3GIsqrlG98N5EDm84BK3K4
- ·1 päivä sittenCould a collaboration with Novo Nordisk be an advantage? They primarily focus on the development of innovative biological medicines but are now also Alzheimer's disease through medical research. Brain+ is, on the other hand, a medtech company that develops digital health solutions for cognitive rehabilitation for citizens with acquired brain injury or dementia. Although both companies operate within the healthcare sector in Denmark, their business areas and methods are different. But they both help to focus on Alzheimer's and they could gather knowledge that both could benefit from, either through shared data or advertising.
- ·23.12.Merry Christmas to everyone here in the forum, hope you all get time to enjoy the time with your families and friends.·24.12.Same to you! 🤗😊.. Also to you two, Overleif and Sir Simon! 🎁🎅🤶🎄..
- ·23.12.If one still can't quite get an overview of what brain+ and Ayla are today, I have made a fact sheet with only data and no noise. 🏛 National and Supranational Health Systems NHS Europe's largest public health system. Defines standards for treatment, evidence, and implementation. Reference for many countries outside the UK. Entry point for national rollout via the ICS structure. If something is accepted here, it is systemically legitimate. World Health Organization Global norm and guideline setter. CST is WHO-recommended. Digital therapeutics with documented effect are prioritized globally. WHO creates global demand – not local pilots. Alzheimer’s Society UK's strongest dementia organization. Professional authority and political voice. Closely linked to NHS, research, and lived experience. Support here = professional endorsement. 🧠 NHS' internal structure NHS Clinical Entrepreneur Programme Selects solutions NHS itself sees scaling potential in. Focus on evidence, implementation, and system fit. NHS says here: “we need to test this one”. Integrated Care Systems 42 regional systems in England. Gathers hospitals, municipalities, care homes, and budgets. This is where rollout decisions are made. Ayla matches the ICS logic: prevention and community care. 🏢 Care sector's power centers Care England The most powerful industry organization for private care homes in the UK. Represents large chains and care groups. Close dialogue with politicians, CQC, and NHS. Access here = access to hundreds of homes. Care Quality Commission Regulator for quality in care homes. Focus on evidence, documentation, medication reduction, and meaningful activity. Ayla directly addresses CQC's criticisms. 🏆 Recognition and legitimacy HSJ Partnership Awards NHS' most prestigious award for partnerships. Shortlisting = national recognition of model and practice, not marketing. UK Dementia Congress National professional platform for dementia. Participation is by invitation. Here the field's common direction is shaped. 🌍 International policy and longevity scenes Longevity Show Gathers WHO, policy, clinical, and system actors. Focus on implementable solutions. Participation signals global relevance. 🇩🇰 Denmark, public welfare systems Danish municipalities: Copenhagen Municipality, Aarhus Municipality, Syddjurs Municipality. Via co-PI, testing, and education. Shows transferability to Nordic welfare systems. 🔗 Overall picture This is not one sector, but an entire ecosystem: Public health system (NHS), regional decision-making structure (ICS), national regulator (CQC), industry organization (Care England), global norm-setter (WHO), national dementia authority (Alzheimer’s Society), international policy scenes, and municipal welfare systems (DK). All are moving in the same direction. 🎯 Conclusion If one still sees Brain+ / Ayla as “a small company hoping for a breakthrough”, one overlooks that they are already working in the right systems, speaking the right language, and being evaluated by the right instances. That is the league where large contracts are formed, often long before the market discovers it.·23.12.B- Leif: as the old proverb says: “birds on the roof are good, many birds on the roof are very good - because suddenly one of them is a GOLDBIRD” So now go and put the Duck on for long-term roasting, Leif 👨🏼🍳🤡
- ·22.12.It will be fun to follow how many 5 kr sales downwards we can count today, after a lift 😅🧐🧐 good day.·22.12.Thought there was an agreement to ignore the price for the rest of 2025 and wait for a green and rising 2026 🤣📈·22.12. · MuokattuI actually think it's more about so much else😊 I feel I have a pretty in-depth insight into the case, so I'm really not that affected by it flying a bit up and down during the day. I just can't help but find it peculiar that we so often see trades that are quite high in level, only to be sold down right after by 5 kr. It's not about frustration at all, it's about wonder and a search for logic. There are several things to it. Firstly, fair enough if you just need 5 kr for the bus. Then you'll have to sell off a bit. Next, there's no economic logic in selling at a loss when you've just seen a higher level. And lastly, why exactly after a larger trade that is 10% higher🤷 The only logical explanation must be that some out there get a kick out of being able to manipulate the market by 10% for 5kr.. and here I'm not thinking of anyone in particular 🧐 I just smile and say thank you very much for another fantastic trade 😅😅 the window at this level is getting shorter and shorter day by day..
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
First North Denmark
Määrä
Osto
3 538 467
Myynti
Määrä
326 000
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| - | - | - | - |
Ylin
0,01VWAP
Alin
0,009VaihtoMäärä
0 2 239 767
VWAP
Ylin
0,01Alin
0,009VaihtoMäärä
0 2 239 767
Välittäjätilasto
Dataa ei löytynyt